Cytek Biosciences, Inc. CTKB Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s change in AP?
- Cytek Biosciences, Inc. (CTKB) reported change in AP of $390K in Q1 2026.
- How has Cytek Biosciences, Inc.'s change in AP changed year-over-year?
- Cytek Biosciences, Inc.'s change in AP decreased by 4.9% year-over-year, from $410K to $390K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.